IP Library Granted Patent US 9,145,580
Granted Patent B2
US 9,145,580 · App. 13/834,142 · Granted Sep 29, 2015

Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,145,580
App. No.
13/834,142
Granted
Sep 29, 2015
Kind
B2
Abstract

Compositions and methods are provided for enriching mitochondrial DNA and optionally chloroplast DNA from eukaryotic cells in a simple rapid method that provides greater than 100 fold enrichment. Affinity protein-coated substrate in a buffer is used to efficiently bind chromosomal DNA and thereby remove it from the buffer. Mitochondrial sequencing reads reveal that non-biased sequence selection providing representation of a substantial proportion of mitochondrial DNA in the eukaryotic cells analyzed.

Claims (30)

1. A composition comprising:

a mixture comprising eukaryotic chromosomal DNA and mitochondrial DNA, wherein the chromosomal DNA in the mixture has a median size of at least 10 kb,

a matrix comprising a protein that comprises a methyl binding domain, wherein the protein is capable of selectively binding to methylated polynucleotides but not non-methylated polynucleotides, and

a buffer containing effective amounts of a salt and a non-ionic detergent.

2. A composition, according to claim 1 , wherein the effective amount of salt is 10 mM-800 Mm.

3. A composition according to claim 1 , wherein the chromosomal DNA is bound to the matrix and a significant portion of the mitochondrial DNA is unbound in the buffer.

4. A composition according to claim 3 , wherein the unbound mitochondrial DNA in the buffer is enriched by at least a 100 fold compared to the mitochondrial DNA in the mixture.

5. A composition according to claim 3 , wherein less than 10% of the chromosomal DNA in the cell DNA is unbound in the buffer.

6. A composition according to claim 3 , wherein less than 10% of the mitochondrial DNA in the mixture is bound to the matrix.

7. A composition according to claim 3 , wherein at least 90% of the mitochondrial DNA and less than 10% of chromosomal DNA is unbound in the buffer.

8. A composition according to claim 1 , wherein the matrix comprises magnetic beads.

9. A composition according to claim 1 , wherein the methyl-binding domain (MBD) is selected from the group consisting of UHRF1(SRA), CXX1, DNMT1, MBD and methyl-binding variants thereof.

10. A composition according to claim 1 , further comprising chloroplast DNA.

11. A composition according to claim 10 , wherein at least 90% of the chloroplast DNA is unbound in the buffer.

12. A method for enriching cellular mitochondrial DNA from a cell sample, comprising:

(a) obtaining a composition according to claim 1 ;

(b) permitting the chromosomal DNA to bind to the matrix; and

(c) obtaining an enriched preparation of mitochondrial DNA in a unbound fraction.

13. A method according to claim 12 , further comprising determining the fraction of the mitochondrial DNA and chromosomal DNA in the unbound fraction.

14. A method according to claim 12 , further comprising, sequencing a part of the entire mitochondrial DNA.

15. A method according to claim 12 , further comprising perfoming a genetic analysis of the mitochondrial DNA.

16. A method according to claim 12 , further comprising perfoming a genetic analysis of single nucleotide polymorphisms in the mitochondrial DNA.

17. A method according to claim 15 , further comprising: analyzing the mitochondrial DNA for oxidative damage.

18. A method according to claim 12 , wherein the methyl-binding domain (MBD) is selected from the group consisting of UHRF1(SRA), CXX1, DNMT1, MBD and methyl-binding variants thereof.

19. A method according to claim 12 , wherein the matrix comprises magnetic beads.

20. A method according to claim 19 , wherein the magnetic beads are coated with protein A bound to MBD2a-Fc.

21. A method for detecting oxidative damage in mitochondrial DNA, comprising:

(a) enriching mitochondrial DNA using the method of claim 12 ;

(b) identifying a change in oxidation status of methylcytosine to hydroxymethylcytosine in chromosomal DNA bound to the MBD as an indicator; and

(c) analyzing the mitochondrial DNA in the unbound fraction for reactive oxygen damage.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2013
From: FEEHERY, GEORGE R.; STEWART, FIONA; MCFARLAND, JAMES; PRADHAN, SHRIHARSA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 030531/0130 →